Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume

Peer Review reports

Original Submission
12 Aug 2019	Submitted	Original manuscript
16 Nov 2019	Reviewed	Reviewer Report - Hans-Christian Kolberg
5 Dec 2019	Reviewed	Reviewer Report - Jinsong Lu
16 Mar 2020	Author responded	Author comments - Bernhard Tribukait
13 Apr 2020	Reviewed	Reviewer Report - Jinsong Lu
28 Apr 2020	Author responded	Author comments - Bernhard Tribukait
Resubmission - Version 2
16 Mar 2020	Submitted	Manuscript version 2
Publishing
3 May 2020	Editorially accepted
18 May 2020	Article published	10.1186/s12885-020-06925-y

Back to article page